US2022205019A1PendingUtilityA1
Oscillating Amplification Reaction For Nucleic Acids
Est. expiryApr 20, 2031(~4.8 yrs left)· nominal 20-yr term from priority
C12P 19/34C12Q 1/686C12Q 2522/101C12Q 1/6844B01L 3/502723C12Q 2527/101
82
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
One embodiment of the present invention provides for a method for amplifying a template of nucleic acid target sequence contained in a sample. The method includes contacting the sample with an amplification reaction mixture containing a primer complementary to the template of nucleic acid target sequence. A temperature of the reaction is oscillated between an upper temperature and a lower temperature wherein the change in temperature is no greater than about 20° C. during a plurality of temperature cycles. The template of nucleic acid target sequence is amplified.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for amplifying a target nucleic acid sequence contained in a sample, the method comprising:
contacting the sample with an amplification reaction mixture comprising a primer complementary to the target nucleic acid sequence; oscillating a temperature of the reaction between an upper temperature and a lower temperature wherein a change in temperature is no greater than about 20° C. during a plurality of temperature cycles; and amplifying the target nucleic acid sequence.
2 . The method of claim 1 wherein the change In temperature is no greater than about 15° C. during a plurality of temperature cycles.
3 . The method of claim 1 wherein the change in temperature is no greater than about 10° C. during a plurality of temperature cycles.
4 . The method of claim 1 wherein the change in temperature is no greater than about 5° C. during a plurality of temperature cycles.
5 . The method of claim 1 wherein upon reaching the upper temperature or the lower temperature, the temperature is maintained for a set period of time within a temperature fluctuation.
6 . The method of claim 1 wherein upon reaching an upper or lower temperature within the temperature range, the temperature is varied to the other temperature.
7 . The method of claim 1 wherein the lower temperature is no less than about 50° C.
8 . The method of claim 1 wherein the upper temperature is no greater than about 85° C.
9 . The method of claim 1 wherein the target nucleic acid sequence comprises single stranded DNA or RNA.
10 . The method of claim 1 wherein the target nucleic acid sequence comprises double stranded DNA or RNA.
11 . The method of claim 1 wherein the target nucleic acid sequence is RNA.
12 . The method of claim 1 wherein the target nucleic acid sequence is DNA.
13 . The method of claim 1 wherein the length of the target nucleic acid sequence is less than about 1000 bp.
14 . The method of claim 1 wherein the length of the target nucleic acid sequence is less than about 250 bp.
15 . The method of claim 1 wherein the length of the target nucleic acid sequence is less than about 150 bp.
16 . The method of claim 1 wherein the length of the target nucleic acid sequence is be less than about 100 bp.
17 . The method of claim 1 wherein the amplification reaction mixture comprises a pair of primers which bind to opposite strands of the target nucleic acid sequence.
18 . The method of claim 17 wherein the each primer of the primer pair has a length and a GC content so that its melting temperature is ≥65° C.
19 . The method of claim 18 wherein the each primer of the primer pair has a length and a GC content so that the melting temperature is ≥70° C.
20 . The method of claim 19 wherein the melting temperature of each primer of the primer pair is between 70-80° C.
21 . The method of claim 17 wherein the each primer of the primer pair has a length of 35-70 base pairs.
22 . The method of claim 17 wherein the pair of primers comprise a forward primer and a reverse primer each having a length of 40-47 base pairs.
23 . The method of claim 1 wherein the amplification reaction mixture comprises a nucleic acid destabilizing agent.
24 . The method of claim 23 wherein the destabilizing agent is selected from the group consisting of dimethylsulfoxlde (DMSO), formamide, Betaine, and combinations thereof.
25 . The method of claim 23 wherein a concentration of the nucleic acid destabilizer is from 8-15 volume percent.
26 . The method of claim 23 wherein the destabilizing agent is a single strand or double strand nucleic acid destabilizing agent.
27 . The method of claim 1 wherein the amplification reaction mixture comprises a DNA polymerase.
28 . The method of claim 27 wherein the DNA polymerase is buffered at a pH to support activity.
29 . The method of claim 27 wherein the DNA polymerase is a thermostable DNA polymerase.
30 . The method of claim 27 wherein the DNA polymerase is selected from the group consisting of TAQ DNA polymerase, VentR DNA polymerase, and DeepVentR DNA polymerase.
31 . The method of claim 27 wherein the DNA polymerase comprises a strand displacing activity.
32 . The method of claim 27 wherein the DNA polymerase does not have 3′−>5′ exonuclease activity.
33 . The method of claim 1 wherein the amplification reaction mixture comprises a reverse transcriptase.
34 . The method of claim 33 wherein the reverse transcriptase is a thermostable reverse transcriptase.
35 . The method of claim 33 wherein the reverse transcriptase is selected from AMV-RT, Superscript II reverse transcriptase, Superscript III reverse transcriptase, or MMLV-RT.
36 . The method of claim 1 wherein the amplification reaction mixture comprises a single stranded binding protein.
37 . The method of claim 36 wherein the single stranded binding protein is a thermal stable single stranded binding protein.
38 . The method of claim 36 wherein the single stranded binding protein is a non-thermal stable single stranded binding protein.
39 . The method of claim 1 wherein the sample is not alcohol free.
40 . The method of claim 1 wherein the sample is not salt free.
41 . The method of claim 1 wherein the upper temperature is a denaturation temperature and a lower temperature is an annealing temperature.
42 . The method of claim 41 wherein the upper denaturation temperature is sufficiently high to completely denature the target nucleic acid sequence.
43 . The method of claim 1 further comprising mixing a solution comprising a divalent cation together with other components to form the amplification reaction mixture.
44 . The method of claim 43 wherein the solution is a buffer.
45 . The method of claim 43 wherein the divalent cation is a salt composing an element selected from the group consisting of magnesium, manganese, copper, zinc and any combination thereof.
46 . The method of claim 43 wherein the solution comprises a monovalent cation.
47 . The method of claim 46 wherein the monovalent cation is a salt comprising an element selected from the group consisting of sodium, potassium, lithium, rubidium, cesium, ammonium and any combination thereof.Join the waitlist — get patent alerts
Track US2022205019A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.